drugset / Trial / NCT02669849
Study to Assess the Efficacy and Safety of VX-210 in Subjects With Acute Traumatic Cervical Spinal Cord Injury
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the efficacy and safety of VX-210 in subjects with Acute Traumatic Cervical Spinal Cord Injury. Secondary objectives include the specific evaluation of the effects of VX-210 on neurological recovery and daily function after spinal cord injury.
Timeline
- Start
- 2016-07
- Primary completion
- 2018-11
- Completion
- 2018-11
Outcome
Missed primary endpoint
registry analysis (superiority test); Placebo vs VX-210 9 mg; p = 0.7519 NCT02669849 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VX-210 | Unknown | — | — |